EMBRACE

A Study of Elranatamab Management With Outpatient and Intermittent Dosing in Relapsed/Refractory Multiple Myeloma

Near Add Your Location

University of Calgary
Arnie Charbonneau Cancer Institute
Calgary, Alberta
  • Not yet accepting
Cross Cancer Institute
Alberta Health Services
Edmonton, AB
  • Not yet accepting
Juravinski Cancer Centre
Juravinski Hospital
Hamilton, ON
  • Not yet accepting
  • Not yet accepting
  • Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.